Rexulti and Aimovig drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rexulti (brexpiprazole) and Aimovig (erenumab-aooe). Common drug interactions include viral infection among females and euphoric mood among males.

The phase IV clinical study analyzes what interactions people have when they take Rexulti and Aimovig. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Rexulti?

Rexulti has active ingredients of brexpiprazole. It is often used in major depression. eHealthMe is studying from 13,394 Rexulti users. Check the latest studies of Rexulti.

What is Aimovig?

Aimovig has active ingredients of erenumab-aooe. eHealthMe is studying from 49,930 Aimovig users. Check the latest studies of Aimovig.

On Jul, 14, 2026

40 people who take Rexulti and Aimovig together, and have interactions are studied.

What are the common drug interactions of Rexulti and Aimovig, by gender? *:

female:

Viral infection
Weight decreased
Fatigue (feeling of tiredness)
Dehydration (dryness resulting from the removal of water)
Memory impairment
Respiratory tract infection viral
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
Allergy to chemicals
Asthma
Dizziness

male:

Euphoric mood (excessively happy but may become angry or irritable)
Suicidal ideation

What are the common drug interactions of Rexulti and Aimovig, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Sinusitis (inflammation of sinus)
Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
Borderline personality disorder
Hospitalisation
Hypertension (high blood pressure)
Insomnia (sleeplessness)
Urinary tract infection
Fatigue (feeling of tiredness)
Headache (pain in head)
Infusion related reaction

40-49:

Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
Asthma
Cardiac disorder
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Headache (pain in head)
Hypersensitivity
Infusion related reaction
Lower limb fracture
Lower respiratory tract infection
Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)

50-59:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Fatigue (feeling of tiredness)

60+:

Bacteraemia (presence of bacteria in the blood)
Influenza
Respiratory tract infection viral
Bacterial infection
Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
Seasonal allergy (allergic condition due to certain season)
Chills (felling of cold)
Cystitis (inflammation of the wall of the bladder)
Dehydration (dryness resulting from the removal of water)
Fall

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 17 people, 42.50%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 27.50%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 17.50%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 10.00%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 4 people, 10.00%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 7.50%
Nausea (feeling of having an urge to vomit): 3 people, 7.50%
Migraine (headache): 3 people, 7.50%
Stress And Anxiety: 2 people, 5.00%
Sleep Disorder: 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Rexulti and Aimovig?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously